148 related articles for article (PubMed ID: 21540238)
1. Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance.
Ponz-Sarvisé M; Nguewa PA; Pajares MJ; Agorreta J; Lozano MD; Redrado M; Pio R; Behrens C; Wistuba II; García-Franco CE; García-Foncillas J; Montuenga LM; Calvo A; Gil-Bazo I
Clin Cancer Res; 2011 Jun; 17(12):4155-66. PubMed ID: 21540238
[TBL] [Abstract][Full Text] [Related]
2. ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling.
Pillai S; Rizwani W; Li X; Rawal B; Nair S; Schell MJ; Bepler G; Haura E; Coppola D; Chellappan S
Mol Cell Biol; 2011 Jul; 31(14):3052-67. PubMed ID: 21606196
[TBL] [Abstract][Full Text] [Related]
3. Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications.
Ponz-Sarvisé M; Castañón E; Panizo-Santos A; Redrado M; López I; Rosell D; Gil-Aldea I; Calvo A; Nguewa PA; Gil-Bazo I
Clin Genitourin Cancer; 2014 Apr; 12(2):87-93. PubMed ID: 24129125
[TBL] [Abstract][Full Text] [Related]
4. GCIP functions as a tumor suppressor in non-small cell lung cancer by suppressing Id1-mediated tumor promotion.
Chen KY; Chen CC; Tseng YL; Chang YC; Chang MC
Oncotarget; 2014 Jul; 5(13):5017-28. PubMed ID: 24970809
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma.
Rothschild SI; Tschan MP; Federzoni EA; Jaggi R; Fey MF; Gugger M; Gautschi O
Oncogene; 2012 Sep; 31(38):4221-32. PubMed ID: 22249264
[TBL] [Abstract][Full Text] [Related]
6. Nicotine-mediated invasion and migration of non-small cell lung carcinoma cells by modulating STMN3 and GSPT1 genes in an ID1-dependent manner.
Nair S; Bora-Singhal N; Perumal D; Chellappan S
Mol Cancer; 2014 Jul; 13():173. PubMed ID: 25028095
[TBL] [Abstract][Full Text] [Related]
7. Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.
Castañon E; Bosch-Barrera J; López I; Collado V; Moreno M; López-Picazo JM; Arbea L; Lozano MD; Calvo A; Gil-Bazo I
J Transl Med; 2013 Jan; 11():13. PubMed ID: 23311395
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner.
Zhao Y; Luo A; Li S; Zhang W; Chen H; Li Y; Ding F; Huang F; Liu Z
J Biol Chem; 2016 Mar; 291(13):6831-42. PubMed ID: 26858249
[TBL] [Abstract][Full Text] [Related]
9. ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial-mesenchymal transition.
Liu K; Chen X; Wu L; Chen S; Fang N; Cai L; Jia J
BMC Pulm Med; 2021 May; 21(1):163. PubMed ID: 33992097
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma.
Rothschild SI; Tschan MP; Jaggi R; Fey MF; Gugger M; Gautschi O
J Thorac Oncol; 2012 Jul; 7(7):1069-77. PubMed ID: 22592211
[TBL] [Abstract][Full Text] [Related]
11. ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis.
Tan HY; Wang N; Chan YT; Zhang C; Guo W; Chen F; Zhong Z; Li S; Feng Y
Cancer Lett; 2020 Apr; 475():109-118. PubMed ID: 32004572
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
Ling YX; Tao J; Fang SF; Hui Z; Fang QR
Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between ID1 and EGFR-TKI Resistance
in Non-small Cell Lung Cancer].
Bao Y; Zhao Y; Chen B; Luo J; Deng Q; Sun H; Xie B; Zhou S
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):864-870. PubMed ID: 27978873
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of Differentiation 1 (ID1) Facilitates the Efficacy of Sorafenib in Non-Small Cell Lung Cancer Cells through Suppressing Epithelial to Mesenchymal Transition.
Zhao YX; Liu J
Med Sci Monit; 2020 Apr; 26():e922148. PubMed ID: 32275644
[TBL] [Abstract][Full Text] [Related]
15. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
16. ZEB1-AS1 is associated with poor prognosis in non-small-cell lung cancer and influences cell migration and apoptosis by repressing ID1.
Jin J; Wang H; Si J; Ni R; Liu Y; Wang J
Clin Sci (Lond); 2019 Jan; 133(2):381-392. PubMed ID: 30626729
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.
Strong N; Millena AC; Walker L; Chaudhary J; Khan SA
Prostate; 2013 May; 73(6):624-33. PubMed ID: 23060149
[TBL] [Abstract][Full Text] [Related]
18. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
Castañón E; Soltermann A; López I; Román M; Ecay M; Collantes M; Redrado M; Baraibar I; López-Picazo JM; Rolfo C; Vidal-Vanaclocha F; Raez L; Weder W; Calvo A; Gil-Bazo I
Cancer Lett; 2017 Aug; 402():43-51. PubMed ID: 28549790
[TBL] [Abstract][Full Text] [Related]
19. The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer.
Rothschild SI; Kappeler A; Ratschiller D; Betticher DC; Tschan MP; Gugger M; Gautschi O
Lung Cancer; 2011 Mar; 71(3):306-11. PubMed ID: 20709421
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Id1 by small interfering RNA in gastric cancer inhibits cell growth via the Akt pathway.
Yang G; Zhang Y; Xiong J; Wu J; Yang C; Huang H; Zhu Z
Mol Med Rep; 2012 Apr; 5(4):1075-9. PubMed ID: 22245935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]